Last quarter (Q ), Generex Biotechnology's total revenue was $20.70K, a decrease of -95.85% from the same quarter last year. In Q, Generex Biotechnology's net income was $9.22M. See Generex Biotechnology’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jul 20	Jul 19	Jul 18	Jul 17	Jul 16
Total Revenue	$ 692.76K	$ 2.66M	$ 6.20M	$ 703.24K	$ 0.00	$ 0.00
Cost of Revenue	$ 358.60K	$ 579.86K	$ 4.14M	$ 0.00	$ 0.00	-
Gross Profit	$ 334.16K	$ 2.08M	$ 2.07M	$ 703.24K	$ 0.00	-
Operating Expense	$ 34.46M	$ 19.82M	$ 23.16M	$ 3.20M	$ 1.60M	$ 1.90M
Operating Income	$ -34.12M	$ -17.74M	$ -21.09M	$ -2.50M	$ -1.60M	$ -1.90M
Net Non Operating Interest Income Expense	$ -3.94M	$ -7.10M	$ -7.04M	$ -583.59K	$ -743.10K	$ -418.50K
Other Income Expense	$ -725.61K	$ -9.39M	$ 17.13M	$ 39.03M	$ -74.49M	$ -902.04K
Pretax Income	$ -38.79M	$ -34.23M	$ -11.01M	$ 35.95M	$ -76.83M	$ -3.22M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -37.26M	$ -33.34M	$ -9.34M	$ 36.33M	$ -70.02M	$ -3.22M
Basic EPS	$ -0.40	$ -0.46	$ -0.14	$ 1.14	$ -2.41	$ -0.13
Diluted EPS	$ -0.52	$ -0.46	$ -0.14	$ 0.47	$ -2.41	$ -0.13
Basic Average Shares	$ 401.93M	$ 73.11M	$ 67.70M	$ 31.82M	$ 29.03M	$ 25.68M
Diluted Average Shares	$ 427.73M	$ 73.11M	$ 67.70M	$ 77.18M	$ 29.03M	$ 25.68M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 34.82M	$ 20.40M	$ 27.30M	$ 3.20M	$ 1.60M	$ 1.90M
Net Income From Continuing And Discontinued Operation	$ -37.26M	$ -33.34M	$ -9.34M	$ 36.33M	$ -70.02M	$ -3.22M
Normalized Income	$ -31.29M	$ -23.07M	$ -26.50M	$ 7.84M	$ 4.48M	$ -2.32M
Interest Expense	$ 4.31M	$ 7.10M	$ 7.09M	$ 583.59K	$ 743.10K	$ 418.50K
EBIT	$ -34.48M	$ -27.13M	$ -3.92M	$ 36.53M	$ -76.09M	$ -2.80M
EBITDA	$ -33.32M	$ -26.12M	$ -3.49M	$ 36.56M	$ -76.08M	$ -2.54M

Currency in USD

Generex Biotechnology Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing